이 보고서는 바이오프로세스 전문가를 대상으로 한 가장 포괄적이고 장기적인 연구입니다. 또한, 업계 동향, 인사이트 및 비즈니스 기회를 조명하고 있습니다.
[업데이트] 올해판에서는 업계 동향과 향후 성장에 대한 분석을 제공하는 주제 전문가를 추가하여 각 장에서 중요한 포인트를 설명합니다. 본 보고서는 505페이지에 달하는 풍부한 데이터 분석으로 생산능력, 생산 동향, 벤치마크 등을 상세히 분석하여 바이오 제조 업무의 의사 결정을 개선하는 데 도움이 될 수 있습니다.
The '2024 21st Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production' is the most comprehensive, longest-running study of bioprocessing professionals. We highlight industry trends, insights, and opportunities.
NEW! This year's edition provides additional Subject Matter Experts providing analysis on trends and future growth, and key takeaways in each chapter! This report's 505 pages of data-rich analysis will help improve your decision making in biomanufacturing operations, with an in-depth analysis of capacity, production trends, benchmarks, and much more.
"It is always a pleasure and honor to contribute to such an important report, capturing the state of the industry." - Stefan Schmidt, CEO, Evitria AG.
"If you really want to get under the skin of the industry, this [BioPlan report] is where you go...Everything you need to know about the biopharma industry is in the BioPlan Annual Report...is the Granddaddy of reports...many pages if you want to get under the skin of the industry, this is where you go." - Dodi Axelson, Discovery Matters Podcast, Dec 2021.
"Your report has delivered significant value to us. We use it as a fundamental part of the research for our strategic planning. This report has helped us see market shifts, such as the predicted increase in needs for biotech-focused CMOd's that we used to position our company to better serve our clients. We consider this a must-have report to keep our business focused in the right direction." - Jeff Hargroves, President, ProPharma Group.
"BioPlan Associates Annual Reports are a valuable independent resource for monitoring drug manufacturing activities, trends and future needs."- Jerold Martin, Former Pall Life Sciences.
"The BioPlan Annual Report and Survey is and has always been a must-read, as it is the most comprehensive survey and results analysis to determine trends, requirements, and new demand of the biopharmaceutical industry. The report's data and interpretation of the survey results are an invaluable tool for biomanufacturers and suppliers alike, as it thoroughly highlights the current status and future necessities. It not only is a snapshot report but a multi-year evaluation." - Maik Jornitz, President, G-Con, LLC.
"I have found each BioPlan Associates' Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production to be particularly useful in my work. As managing editor for BioProcessing Journal, I refer to my print copies of the biomanufacturing survey reports regularly when recruiting and editing manuscripts. They are valuable components of my journal production 'toolkit.'"- Marci J. Brown, Managing Editor, BioProcessing Journal.